-Frontline PESA, which is seen as an enabling law for tribal self-governance, is violated brazenly by both the Union government and State governments in the name of development. SINCE October 2012, the Ministry of Rural Development of the United Progressive Alliance (UPA) government has apparently been engaged in an exercise to evolve a "National Land Reforms Policy". Over these months, the Ministry wrote to various State governments, highlighting the importance of...

-The Times of India In a significant move towards transparency, the government on Tuesday said all public authorities should proactively disclose information related to public private partnerships (PPP) projects on their websites. Though the disclosure will be voluntary, this marks a shift from the Centre's stand for the last two years when it stonewalled Central Information Commission (CIC)'s recommendation seeking disclosure of PPP projects and will herald greater transparency. Guidelines issued by the...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

-The Hindu   Entering third polio-free year, India must destroy all wild poliovirus lab samples by December Having successfully completed two polio-free years, India is preparing to receive the crucial polio eradication certificate from the World Health Organisation (WHO). The certificate is issued on completion of incident-free three years. This primarily involves the destruction or safe storage of all laboratory sources of wild poliovirus. The storage should be in laboratories that meet international standards...

-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...